CYTH - Cyclo Therapeutics GAAP EPS of -$2.24 misses by $0.36 revenue of $1.58M misses by $0.48M March, 14 2022 08:17 AM Cyclo Therapeutics Inc. Cyclo Therapeutics press release (NASDAQ:CYTH): FY GAAP EPS of -$2.24 misses by $0.36. Revenue of $1.58M (+75.6% Y/Y) misses by $0.48M. For further details see: Cyclo Therapeutics GAAP EPS of -$2.24 misses by $0.36, revenue of $1.58M misses by $0.48M